Back to Authors

Li, Xiaogang

https://orcid.org/0000-0001-8135-342X

Mayo Clinic

Mayo Clinic

Citations 63

Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases
Xie, Tiancheng, Yao, Li , Li, Xiaogang

Antioxidants | May 28, 2024 | Volume: 13 | Issue: 6 | Pages: 659

10.3390/antiox13060659 Get It

Kidney diseases pose a significant global health issue, frequently resulting in the gradual decline of renal function and eventually leading to end-stage renal failure. Abnormal iron metabolism and oxidative stress-mediated cellular dysfunction facilitates the advancement of kidney diseases. Iron homeostasis is strictly regulated in the body, and disturbance in this regulatory system results in abnormal iron accumulation or deficiency, both of which are associated with the pathogenesis of kidney diseases. Iron overload promotes the production of reactive oxygen species (ROS) through the Fenton reaction, resulting in oxidative damage to cellular molecules and impaired cellular function. Increased oxidative stress can also influence iron metabolism through upregulation of iron regulatory proteins and altering the expression and activity of key iron transport and storage proteins. This creates a harmful cycle in which abnormal iron metabolism and oxidative stress perpetuate each other, ultimately contributing to the advancement of kidney diseases. The crosstalk of iron metabolism and oxidative stress involves multiple signaling pathways, such as hypoxia-inducible factor (HIF) and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways. This review delves into the functions and mechanisms of iron metabolism and oxidative stress, along with the intricate relationship between these two factors in the context of kidney diseases. Understanding the underlying mechanisms should help to identify potential therapeutic targets and develop novel and effective therapeutic strategies to combat the burden of kidney diseases.
Epigenetic Age Is Accelerated in ADPKD Kidneys and Is Regulated by Autophagy-Mediated DNA Methyltransferase
Li, Xiaoyan , Calvet, James P. , Li, Lu , Harris, Peter C. , Li, Xiaogang

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 561-562

10.1681/asn.20233411s1561e Get It

Pkd1 Mutation Causes Memory Impairment Driving by Cellular Senescence in ADPKD
Firdaus, Zeba , Mao, Xinyue, Lu, Li , Zhou, Xia, Li, Xiaoyan , Harris, Peter C. , Li, Xiaogang

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 560-560

10.1681/asn.20233411s1560a Get It

The Immune Checkpoint Protein PD-L1 Interacts with BBS5 to Regulate Ciliogenesis and Hedgehog Signaling
Agborbesong, Ewud , Li, Xiaoyan , Zhou, Xia , Calvet, James P. , Harris, Peter C. , Li, Xiaogang

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 563-563

10.1681/asn.20233411s1563c Get It

Progressive Cellular Senescence Promotes and Senolytic Therapy Delays Cyst Growth in ADPKD
Mao, Xinyue , Lu, Li , Zhou, Xia, Mao, Xinyue, Harris, Peter C. , Li, Xiaogang

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 558-558

10.1681/asn.20233411s1558b Get It

Identification and Characterization of Biomarkers from Cell-Free DNA Methylation in ADPKD Patients
Li, Xiaoyan, Zhou, Xia , Hanna, Christian , Harris, Peter C. , Li, Xiaogang

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 210-210

10.1681/asn.20233411s1210b Get It

Targeting ALDH1A1 with Nanoparticle-Based Immunotherapy on Kidney PD-L1 Synergistically Delays Cyst Growth
Cheng, Shasha, Li, Xiaoyan , Zhou, Xia, Calvet, James P. , Li, Xiaogang

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 205-205

10.1681/asn.20233411s1205c Get It

Therapeutic Blocking of IL-17A Binding to IL-17RA Diminishes PD-L1 Expression Is a Novel Therapeutic Approach for ADPKD
Samarpita, Snigdha , Agborbesong, Ewud , Zhou, Xia , Li, Xiaoyan , Torres, Vicente E. , Li, Xiaogang

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 205-205

10.1681/asn.20233411s1205b Get It

Establishment and Application a Novel Reversible Unilateral Ureteral Obstruction (RUUO) Mouse Model and in Mechanism Study of AKI to CKD
Mao, Xinyue , Li, Bing , Mao, Xinyue, Li, Xiaogang

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 704-704

10.1681/asn.20233411s1704b Get It

SMYD3 Regulates Cyst Growth and Ciliogenesis in Autosomal Dominant Polycystic Kidney Disease
Agborbesong, Ewud , Zhou, Xia , Li, Xiaoyan , Li, Xiaogang

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 398-398

10.1681/asn.20223311s1398c Get It